Caroline E Boeke1, Rulla M Tamimi2, Catherine S Berkey3, Graham A Colditz4, A Heather Eliassen2, Susan Malspeis5, Walter C Willett6, A Lindsay Frazier7. 1. Departments of Epidemiology and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; caroline.boeke@mail.harvard.edu. 2. Departments of Epidemiology and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts; 3. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts; 4. Alvin J. Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri; and. 5. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; 6. Departments of Epidemiology and Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts; Nutrition, Harvard School of Public Health, Boston, Massachusetts; 7. Division of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Abstract
BACKGROUND: Carotenoids may reduce risk of benign breast disease (BBD), an independent risk factor for breast cancer, through antioxidative or antiproliferative mechanisms. Exposure to carotenoids may be most important during adolescence when breast tissue is still developing. We examined adolescent carotenoid intake in relation to BBD in young women. METHODS: In 6593 adolescent girls in the prospective Growing Up Today Study cohort, intakes of α-carotene, β-carotene, β-cryptoxanthin, lutein/zeaxanthin, and lycopene were assessed by using the means from food-frequency questionnaires in 1996, 1997, and 1998. Girls reported biopsy-confirmed BBD on questionnaires in 2005, 2007, and 2010 (n = 122). We conducted logistic regression of energy-adjusted carotenoid intakes in relation to BBD, adjusted for age, family history of breast cancer or BBD, age at menarche, nulliparity, alcohol intake, BMI, and physical activity. RESULTS: Mean (SD) age at baseline was 12.0 (1.6) years. β-Carotene intake was inversely associated with BBD; comparing the highest to lowest quartile, the multivariate-adjusted odds ratio was 0.58 (95% confidence interval: 0.34-1.00; P-trend = .03). α-Carotene and lutein/zeaxanthin were also inversely associated with BBD, but the associations were not statistically significant. CONCLUSIONS: Adolescent carotenoid intake may be associated with lower BBD risk; these findings warrant further study.
BACKGROUND:Carotenoids may reduce risk of benign breast disease (BBD), an independent risk factor for breast cancer, through antioxidative or antiproliferative mechanisms. Exposure to carotenoids may be most important during adolescence when breast tissue is still developing. We examined adolescent carotenoid intake in relation to BBD in young women. METHODS: In 6593 adolescent girls in the prospective Growing Up Today Study cohort, intakes of α-carotene, β-carotene, β-cryptoxanthin, lutein/zeaxanthin, and lycopene were assessed by using the means from food-frequency questionnaires in 1996, 1997, and 1998. Girls reported biopsy-confirmed BBD on questionnaires in 2005, 2007, and 2010 (n = 122). We conducted logistic regression of energy-adjusted carotenoid intakes in relation to BBD, adjusted for age, family history of breast cancer or BBD, age at menarche, nulliparity, alcohol intake, BMI, and physical activity. RESULTS: Mean (SD) age at baseline was 12.0 (1.6) years. β-Carotene intake was inversely associated with BBD; comparing the highest to lowest quartile, the multivariate-adjusted odds ratio was 0.58 (95% confidence interval: 0.34-1.00; P-trend = .03). α-Carotene and lutein/zeaxanthin were also inversely associated with BBD, but the associations were not statistically significant. CONCLUSIONS: Adolescent carotenoid intake may be associated with lower BBD risk; these findings warrant further study.
Authors: Catherine S Berkey; Walter C Willett; Rulla M Tamimi; Bernard Rosner; A Lindsay Frazier; Graham A Colditz Journal: Breast Cancer Res Treat Date: 2013-09-17 Impact factor: 4.872
Authors: W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer Journal: Am J Epidemiol Date: 1985-07 Impact factor: 4.897
Authors: Kevin Cohen; Ying Liu; Jingqin Luo; Catherine M Appleton; Graham A Colditz Journal: Breast Cancer Res Treat Date: 2017-02-11 Impact factor: 4.872
Authors: Xuefen Su; Caroline E Boeke; Laura C Collins; Heather J Baer; Walter C Willett; Stuart J Schnitt; James L Connolly; Bernard Rosner; Graham A Colditz; Rulla M Tamimi Journal: Cancer Causes Control Date: 2014-11-07 Impact factor: 2.506
Authors: Rita Peila; Rowan T Chlebowski; Tarah J Ballinger; Victor Kamensky; Phyllis A Richey; Nazmus Saquib; Aladdin H Shadyab; Sylvia Wassertheil-Smoller; Thomas E Rohan Journal: Int J Epidemiol Date: 2021-06-17 Impact factor: 9.685
Authors: Megan S Rice; A Heather Eliassen; Susan E Hankinson; Elizabeth B Lenart; Walter C Willett; Rulla M Tamimi Journal: Am J Public Health Date: 2016-07-26 Impact factor: 9.308
Authors: James L Nodler; Holly R Harris; Jorge E Chavarro; A Lindsay Frazier; Stacey A Missmer Journal: Am J Obstet Gynecol Date: 2019-09-14 Impact factor: 8.661
Authors: Nancy E Moran; Jennifer M Thomas-Ahner; Lei Wan; Krystle E Zuniga; John W Erdman; Steven K Clinton Journal: J Nutr Date: 2022-06-09 Impact factor: 4.687
Authors: Javier Torregrosa-Crespo; Zaida Montero; Juan Luis Fuentes; Manuel Reig García-Galbis; Inés Garbayo; Carlos Vílchez; Rosa María Martínez-Espinosa Journal: Mar Drugs Date: 2018-06-08 Impact factor: 5.118